The following information has been compiled from publicly available sources,
StratCom does not assume any responsibility for the accuracy or the authenticity
of the information and StratCom cannot be held liable for errors.
Cepheid launched its first Analyte Specific Reagent products - primer and probe sets for Bordetella pertussis and HSV. This program is the beginning of a growing menu of Cepheid ASR products for use on real-time PCR instruments and the company's SmartCycler System.
LightUp Technologies AB and DakoCytomation A/S introduced the ReSSQ EBV Assay. The tests has been validated on Roche's LightCycler and the ABI PRISM 7000 SDS real-time PCR instrument platforms.
PerkinElmer Inc. and Predictive Diagnostics, Inc. entered into a partnership adapt PDI's proprietary Biomarker Amplification Filter (BAMF) Technology for PerkinElmer's prOTOF 2000 MALDI O-TOF mass spectrometer. The new system is designed for drug discovery.
QIAGEN N.V. acquired the key assets of Molecular Staging, Inc. and its Multiple Displacement Amplification (MDA) technology.
Affymetrix, Inc., and Roche Diagnostics have been awarded the CE Mark for their GeneChip System 3000Dx and the Roche AmpliChip CYP450 Test.
![[Page Banner Image]](images/hmole.gif){kind=small}
![[HRule Image]](images/div.jpg){kind=small}
